
Nimbus Therapeutics
Get Full AccessDescription
- Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA). With its breakthrough computational chemistry platform, enabled through its privileged partnership with co-founder, Schrödinger, Inc., Nimbus is pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The companys focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.
-
Headquarters:130 Prospect Street Suite 301, Cambridge, Massachusetts, United States
More -
Phone Number: +1 857-999-2009
-
Website: https://www.nimbustx.com
-
Employees:49
-
Revenue:$50 - 100M
-
Legal Name:Nimbus Therapeutics
-
Nimbus Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Frequently Asked Questions regarding Nimbus Therapeutics
-
Where are Nimbus Therapeutics's Headquarters?
Nimbus Therapeutics's Headquarters are in 130 Prospect Street Suite 301,Cambridge,Massachusetts,United States
-
What is Nimbus Therapeutics's phone number?
Nimbus Therapeutics's phone number is +1 857-999-2009
-
What is Nimbus Therapeutics's official website?
Nimbus Therapeutics's official website is https://www.nimbustx.com
-
What is Nimbus Therapeutics's Revenue?
Nimbus Therapeutics's revenue is $50 - 100M
-
What is Nimbus Therapeutics's NAICS code?
Nimbus Therapeutics's NAICS code is 541714
-
How many employees are working in Nimbus Therapeutics
Nimbus Therapeutics has 49 employees
-
What is Nimbus Therapeutics's Industry?
Nimbus Therapeutics is in the industry of Biotechnology
-
Who is Nimbus Therapeutics's CEO?
Nimbus Therapeutics's CEO is Amy Schnall-Romanowski